Activation of the Pro-survival Phosphatidylinositol 3-Kinase/AKT Pathway by Transforming Growth Factor-β1 in Mesenchymal Cells Is Mediated by p38 MAPK-dependent Induction of an Autocrine Growth Factor
Open accessThe DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Transforming growth factor-beta1 (TGF-beta1) is a multifunctional cytokine involved in differentiation, growth, and survival of mesenchymal cells while inhibiting growth/survival of most other cell types. The mechanism(s) of pro-survival signaling by TGF-beta1 in mesenchymal cells is unclear. In this report, we demonstrate that TGF-beta1 protects against serum deprivation-induced apoptosis of mesenchymal cells isolated from patients with acute lung injury and of normal human fetal lung fibroblasts (IMR-90). TGF-beta receptor(s)-activated signaling in these cells involves rapid activation of the Smad and p38 MAPK pathways within minutes of TGF-beta1 treatment followed by a more delayed activation of the pro-survival phosphatidylinositol 3-kinase-protein kinase B (PKB)/Akt pathway. Pharmacological inhibition of p38 MAPK with SB203580 or expression of a p38 kinase-deficient mutant protein inhibits TGF-beta1-induced PKB/Akt phosphorylation. Conditioned medium from TGF-beta1-treated cells rapidly induces PKB/Akt activation in an SB203580- and suramin-sensitive manner, suggesting p38 MAPK-dependent production of a secreted growth factor that activates this pro-survival pathway by an autocrine/paracrine mechanism. Inhibition of the phosphatidylinositol 3-kinase-PKB/Akt pathway blocks TGF-beta1-induced resistance to apoptosis. These results demonstrate the activation of a novel TGF-beta1-activated pro-survival/anti-apoptotic signaling pathway in mesenchymal cells/fibroblasts that may explain cell-specific actions of TGF-beta1 and provide mechanistic insights into its pro-fibrotic and tumor-promoting effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The use of p38 MAPK inhibitors also lowers TGFβ-induced collagen type I and αSMA production and prevents TGFβ-induced AKT signaling (53–55).”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [55]
Citations
Cites
The Acute Respiratory Distress Syndrome
Matthay, M. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605303342209 · Cited by 4,923
The Acute Respiratory Distress Syndrome
Ware, L. B., & Matthay, M. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421806 · Cited by 4,666
Myofibroblasts and mechano-regulation of connective tissue remodelling
Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C., & Brown, R. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm809 · Cited by 4,290
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
Specificity and mechanism of action of some commonly used protein kinase inhibitors
DAVIES, S. P., REDDY, H., CAIVANO, M., & COHEN, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,132
Transforming Growth Factor β in Tissue Fibrosis
Epstein, F. H., Border, W. A., & Noble, N. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311907 · Cited by 3,069
Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V, & Kehrl, J. H. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4167 · Cited by 2,866
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
Research works printed but not linked: 3
- Desmouliere, 1995, Am. J. Pathol., 146, 56
- Janin, 1990, Clin. Exp. Rheumatol., 8, 237
- Valdes, 2002, Mol. Cancer Res., 1, 68
Cited by
Items 201–239 of 239
Transforming growth factor-beta in the pathogenesis of chronic obstructive pulmonary disease
Liebhart, J., & Dobek, R. (2008) · Journal of Organ Dysfunction · doi:10.1080/17471060701721985 · Cited by 5
Double, double toil and trouble: transforming growth factor beta (TGF-β) in HIV infection
Harrison-Gleason, J., Yerlioglu, K. L., Halle, A. W. T., Hultquist, J. F., & Martinelli, E. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1738092 · Cited by 5
Zhang, L. (2019) · Global Medical Genetics · doi:10.3934/genet.2019.2.11 · Cited by 4
PTEN-restoration abrogates brain colonisation and perivascular niche invasion by melanoma cells
Wang, S., Riedstra, C. P., Zhang, Y., Anandh, S., & Dudley, A. C. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02530-5 · Cited by 5
Concomitant Idiopathic Pulmonary Fibrosis and Lung Cancer: An Updated Narrative Review
Czyżak, B., & Majewski, S. (2025) · Advances in respiratory medicine · doi:10.3390/arm93040031 · Cited by 9
“This leads to the activation of downstream signaling of pro-fibrotic growth factors such as PDGF and TGF-β , promoting fibroblast proliferation and differentiation [23,97,98].”
Jung, M., Lin, T., & Sonia, B. (2012) · InTech eBooks · doi:10.5772/25948 · Cited by 4
“Activation of the AKT pathway by TGF-β1 has been shown to be mediated by a p38 MAPK-mediated mechanism (Horowitz et al., 2004).”
BackgroundLack of aminoacids in mouse hepatocytes in culture induces the selection of preneoplastic cells
Chisari, A. N., Echarte, S. M., Podaza, E., & Fabregat, I. (2012) · BMC Proceedings · doi:10.1186/1753-6561-6-s3-p13 · Cited by 4
Lee, S.-J. (2010) · Journal of the Korean Society for Applied Biological Chemistry · doi:10.3839/jksabc.2010.114 · Cited by 4
“Recently, evidence has emerged that p38 MAPK, one of the MAPKs, play a crucial role in both the promotion and inhibition of apoptosis [Galan et al., 2000; Horowitz et al., 2004].”
BackgroundAyala, P., Torres, J., Vivar, R., Meneses, M. F., Olmos, P. R., Martin, T. S., & Borzone, G. R. (2018) · Respiratory Research · doi:10.1186/s12931-018-0763-6 · Cited by 4
“posed to typical pro-apoptotic stimuli [30, 31].”
Protective effect of skin‐derived precursors on photoaging in nude mice
Wang, S., Zhong, J., & Li, L. (2018) · Australasian Journal of Dermatology · doi:10.1111/ajd.12867 · Cited by 4
Myofibroblast Functions in Tissue Repair and Fibrosis: An Introduction
Thannickal, V. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_2 · Cited by 6
Self-citationBerhan, A., Gunatilaka, A., Lee, C.-W., Zhang, S., Tan, D., Harris, T., Jaffar, J., Jativa, F., Lönnstedt, I. M., Alhamdoosh, M., et al. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2025-0030oc · Cited by 3
Transforming growth factor β signaling in colorectal cancer
Grady, W. M. (2007) · Current Colorectal Cancer Reports · doi:10.1007/s11888-007-0002-x · Cited by 2
“The regulation of the response appears to be dependent on whether the TGF-C receptor can activate nonSmad pathways and on the activation state of other signaling pathways [37,41, 42 ].”
[Progress in myofibroblast and its application in forensic medicine].
Yu, T.-S., Yue, L., & Guan, D.-W. (2013) · PubMed · Cited by 1
Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer
Li, Y., Liu, C., Tang, K., Chen, Y., Tian, K., Feng, Z., & Chen, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8179 · Cited by 1
Cellular and Molecular Mechanisms of Fibrosis in Systemic Sclerosis
Trojanowska, M., Varga, J., & Lagares, D. (2024) · Springer eBooks · doi:10.1007/978-3-031-40658-4_18 · Cited by 2
Cellular mechanisms of myofibroblast differentiation and dysfunctions in wound healing
Midgley, A. C. (2014) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Transforming Growth Factor Signaling in Colorectal Cancer
Grady, W. M. (2007)
Amiri, M. (2014) · Scholarship@Western (Western University)
Ganjre, A. P. (2017) · Archives of Pathology and Clinical Research · doi:10.29328/journal.hjpcr.1001001
“Thus, initiation of P13/AKT pathway results in induction of “anoikis resistant phenotype” to MF at the time of EMT [15].”
BackgroundGanjre, A. P. (2018) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_6_16
BH3 Mimetic Drugs for Anti-fibrotic Therapy
Lagares, D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00235
R-Ras Proteins and TGF-Beta in Cancer
Erdogan, M. (2008)
Sandbo, N. K. (2018) · Respiratory medicine · doi:10.1007/978-3-319-99975-3_7
RIPK3 Expression in Fibroblasts in an in vivo and in vitro Skin Wound Model: A Controversial Result
Izumov, I. S., Shitova, M. S., Sabirov, M. S., Sheleg, S. A., Cherkashina, O. L., Kalabusheva, E. P., Vorotelyak, E. A., & Morgun, E. I. (2024) · Acta Naturae · doi:10.32607/actanaturae.25452
Zhao, R., Liu, X., Liu, J., Wang, H., Cui, Y., Yu, R., Jin, T., Wang, S., Qin, X., Wang, M., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119949
TGF-ß Signaling Pathway and Colorectal Cancer
Grady, W. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8412-7_7
Rôle de la voie hedgehog dans la fibrose pulmonaire idiopathique
Moshai, E. F. (2013) · theses.fr (ABES) · doi:10.70675/b550340ez33a1z43b7zb4eez8c2cfde874df
Traitement de la fibrose pulmonaire idiopathique : Rôle de TRIM33 et de l’inhibition d’HSPB5
Boutanquoi, P. (2019) · theses.fr (ABES) · doi:10.70675/968e196dz45c0z4010za2dez22d692e030cc
Bertrand‐Chapel, A. (2021) · theses.fr (ABES) · doi:10.70675/6f1078b7z94d3z4096z85a9z40b435cd6a59
NADPH Oxidases and Pulmonary Fibrosis
Deskin, B., & Thannickal, V. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-21135-4_22
Self-citationPathological Interplay of ROS With Myofibroblasts: An Impediment to Corneal Restitution
Karimi, M. Y., & Colagar, A. H. (2026) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/5547254
“…this pathway can lead to pathological survival of myo fi broblasts in insulted corneas [58, 59], as it enhances ECM production and resistance to apoptosis through the activation of pathways such as FAK-PI 3 K/ AKT and p38 MAPK and suppression of both extrinsic and intrinsic apoptosis [3, 55, 154].”
Eedara, A., Jeyasankari, S., Chandra, Y., Muralidharan, K., & Andugulapati, S. B. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10978-x
“Crosstalk between these pathways may further contribute to fibrosis progres - sion, as p38 MAPK has been reported to facilitate PI3K/ Akt activation (Horowitz et al. 2004 ; Wygrecka et al. 2012 ).”
Investigating a co-operative link between TGF-β and Lyn kinase in Chronic Myeloid Leukaemia
Smith, P. (2011) · UEA Digital Repository (University of East Anglia)
Metadata
- Authors
- Horowitz, J. C., Lee, D. Y., Waghray, M., Keshamouni, V. G., Thomas, P. E., Zhang, H., Cui, Z., & Thannickal, V. J.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Thannickal, Victor J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 279
- Issue
- 2
- Pages
- 1359-1367
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC1360222
- OpenAlex
- W1965916788
- Cited by
- 239
- References
- 55
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 4 · 2023: 6 · 2022: 3 · 2021: 9 · 2020: 2 · 2019: 13 · 2018: 13 · 2017: 9 · 2016: 15 · 2015: 9 · 2014: 10 · 2013: 12 · 2012: 14
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6145 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P50HL074024, R01-HL-67967, R01HL067967, P50 HL-74021)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- TGF-β1, PI3K/Akt signaling, p38 MAPK, mesenchymal cells, lung fibroblasts, apoptosis resistance, autocrine growth factor, Smad signaling, acute lung injury, pulmonary fibrosis
- MeSH terms
- Cell Division, Cell Survival, Cells, Cultured, Densitometry, DNA, Single-Stranded, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Enzyme-Linked Immunosorbent Assay, Fibroblasts, Growth Substances, Humans, Imidazoles, Lung, Mesoderm, Microscopy, Fluorescence, Models, Biological, Mutation, Phenotype, Phosphorylation, Plasmids, Pyridines, Time Factors, Blotting, Western, Signal Transduction, Cytokines, Transforming Growth Factor beta, Culture Media, Conditioned, Apoptosis, Phosphatidylinositol 3-Kinases, Caspases, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Caspase 3, Transforming Growth Factor beta1, Transforming Growth Factor beta2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.